Activation of dectin-1 induces the production of pro-inflammatory cytokines, chemokine [6], and reactive oxygen species [7], and dectin-1 is suggested to play a role in obesity-associated inflammation and insulin resistance, making it a therapeutic target in the treatment of chronic inflammation in insulin-resistant individuals [8]. Here, CLEC7A is linked to obesity disorder.